Product Recalls: September 12, 2018 – October 10, 2018

Health Letter, November 2018

Note: Never stop taking a drug that appears on the product recall list without first talking to your doctor or pharmacist. Most recalls are limited to a single manufacturer and may not be related to the version of a particular drug you are taking. If a recall does relate to the version of the drug you are taking, you should not stop taking the drug until you discuss an alternative treatment with your doctor or pharmacist.

CLASS I

Hydrochlorothiazide tablets, 12.5 mg, 100-count bottle. Manufactured for: Accord Healthcare, Inc.

Robaxin-750 (methocarbamol) tablets, 750 mg, 100-count bottle. Distributed by: Endo Pharmaceuticals Inc. Manufactured by: Kremers Urban Pharmaceuticals Inc.

CLASS II

Clozapine orally disintegrating tablets, 12.5 mg, 100-count bottles. Manufactured by: Teva Pharmaceuticals USA, Inc.

Lamotrigine extended-release tablets, 200 mg, 30-count bottle. Manufactured for: Torrent Pharma Inc.

Montelukast sodium tablets, 10 mg, 30-count bottles. By: Hetero, Hetero Labs Limited.

Synjardy (empagliflozin and metformin hydrochloride) tablets, 5 mg/1000 mg, 180-count bottle. Distributed by: Boehinger Ingelheim (BI) Pharmaceuticals, Inc.

Tizanidine HCl tablets, 2 mg, 150-count bottles. Manufactured by: Dr. Reddy’s Laboratories Limited.

For more information about the drug recalls listed above, please visit http://www.accessdata.fda.gov/scripts/ires/index.cfm.

CONSUMER PRODUCTS

For a list of recent recalls of consumer products, please visit the Consumer Product Safety Commission website at http://www.cpsc.gov/en/Recalls/.